Page last updated: 2024-11-02
pentoxifylline and Kaposi Sarcoma
pentoxifylline has been researched along with Kaposi Sarcoma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Dezube, BJ | 1 |
| Pardee, AB | 1 |
| Chapman, B | 1 |
| Beckett, LA | 1 |
| Korvick, JA | 1 |
| Novick, WJ | 1 |
| Chiurco, J | 1 |
| Kasdan, P | 1 |
| Ahlers, CM | 1 |
| Ecto, LT | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS[NCT00000646] | Phase 1 | 54 participants | Interventional | | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for pentoxifylline and Kaposi Sarcoma